Designed to provide medium- to long-term central venous access for the administration of fluids and medications and for blood sampling.
Designed in collaboration with cardiologists to solve the most common challenges in radial hemostasis.
Proprietary Endexo® technology provides a catheter material more resistant to the accumulation of blood components (platelets and thrombus).
PASV™ valves provides a closed system, minimising blood reflux. These have been shown to reduce catheter infection.
Available in single, dual, and triple lumen configurations, in 3–6 French sizes, valved (PASV) or non-valved, with power-injectable options.
The SV BioFlo PICC is designed to reduce the risk of catheter-related occlusion and thrombosis, keeping the line reliable for the duration of therapy while reducing exposure-related risks.
Suited to both short and long-term IV therapy, the SV BioFlo PICC are intended to give clinicians confidence in catheter performance from insertion through to removal.
Connect with our product specialists for bulk orders and institutional inquiries.
| Sterility | EO sterile |
| Legal Manufacturer | Spectrum Vascular |
| Country of Origin | USA |
| Shelf Life/Expiry | 3 years |
| Customisation | Non-customisable |
| Regulatory Status | CE Marked |
| Lumens | 1-3 lumens |
There is no information to display.
